Search Results - Charles Linker

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901

    Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901 by Thomas C. Shea, Jeffrey L. Johnson, Peter Westervelt, Sherif S. Farag, John M. McCarty, Asad Bashey, Luis Isola, Lee-Anne Baxter-Lowe, Michael E. Kelly, Kouros Owzar, Charles Linker

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)

    Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy... by Ivan Borrello, Hyam I. Levitsky, Wendy Stock, Dorie Sher, Qin Lu, Daniel J. DeAngelo, Edwin P. Alyea, Richard M. Stone, Lloyd E. Damon, Charles Linker, Daniel Maslyar, Kristen Hege

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Phase II Study of High-Dose [<sup>131</sup>I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma

    Phase II Study of High-Dose [<sup>131</sup>I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma by Sara L. Gonias, Robert E. Goldsby, Katherine K. Matthay, Randall A. Hawkins, David C. Price, John P. Huberty, Lloyd E. Damon, Charles Linker, Aimee Sznewajs, Steve Shiboski, Paul A. FitzGerald

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303

    Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remissi... by Steven M. Devine, Shelly Carter, Robert J. Soiffer, Marcelo C. Pasquini, Parameswaran Hari, Anthony S. Stein, Hillard M. Lazarus, Charles Linker, Edward A. Stadtmauer, Edwin P. Alyea, Carolyn A. Keever-Taylor, Richard J. O’Reilly

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303

    Characteristics of CliniMACS® System CD34-Enriched T Cell-Depleted Grafts in a Multicenter Trial for Acute Myeloid Leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT... by Carolyn A. Keever-Taylor, Steven M. Devine, Robert J. Soiffer, Adam Mendizabal, Shelly Carter, Marcelo C. Pasquini, Parameswaran Hari, Anthony S. Stein, Hillard M. Lazarus, Charles Linker, Steven C. Goldstein, Edward A. Stadtmauer, Richard J. O’Reilly

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909

    Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909 by Lloyd E. Damon, Jeffrey L. Johnson, Donna Niedzwiecki, Bruce D. Cheson, David D. Hurd, Nancy L. Bartlett, Ann S. LaCasce, Kristie A. Blum, John C. Byrd, Michael E. Kelly, Wendy Stock, Charles Linker, George P. Canellos

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

    A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease by Margaret L. MacMillan, Daniel Couriel, Daniel J. Weisdorf, Gisela Schwab, N. Havrilla, Thomas R. Fleming, Saling Huang, Lorin Roskos, Shimon Slavin, Richard K. Shadduck, John F. DiPersio, Mary Territo, Steve Pavletic, Charles Linker, Helen E. Heslop, H. Joachim Deeg, Bruce R. Blazar

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Polymyositis as a Manifestation of Chronic Graft-Versus-Host Disease

    Polymyositis as a Manifestation of Chronic Graft-Versus-Host Disease by Pablo Parker, N J Chao, Johnathan Ben-Ezra, Neal E. Slatkin, Harry Openshaw, Joyce C. Niland, Charles Linker, Brian Greffe, Ashwin Kashyap, Arturo Molina, Auayporn Nademanee, Margaret O’Donnell, Ina Planás, Khalil Sheibani, Eileen Smith, David S. Snyder, Ricardo Spielberger, Anthony S. Stein, Daniel E. Stepan, Karl G. Blume, Stephen J. Forman

    Published 1996
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

    Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From... by Steven M. Devine, Kouros Owzar, William Blum, Flora Mulkey, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, Yi‐Bin Chen, Ravi Vij, James L. Slack, Robert J. Soiffer, Richard A. Larson, Thomas C. Shea, Vera Hárs, Alexander B. Sibley, Sergio Giralt, Shelly Carter, Mary M. Horowitz, Charles Linker, Edwin P. Alyea

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

    A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation by Steven H. Bernstein, Auayporn Nademanee, Julie M. Vose, Guido Tricot, Joseph W. Fay, Robert S. Negrin, John F. DiPersio, Gabriela Rondón, Richard E. Champlin, Michael J. Barnett, Kenneth Cornetta, Geoffrey P. Herzig, William P. Vaughan, George F. Geils, Armand Keating, Hans A. Messner, Steven N. Wolff, Kenneth B. Miller, Charles Linker, Mitchell S. Cairo, Susan Hellmann, Mark Ashby, Scott Stryker, Richard A. Nash

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation

    A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation by Steven H. Bernstein, Auayporn Nademanee, Julie M. Vose, Guido Tricot, Joseph W. Fay, Robert S. Negrin, John F. DiPersio, Gabriela Rondón, Richard E. Champlin, Michael J. Barnett, Kenneth Cornetta, Geoffrey P. Herzig, William P. Vaughan, George F. Geils, Armand Keating, Hans A. Messner, Steven N. Wolff, Kenneth B. Miller, Charles Linker, Mitchell S. Cairo, Susan Hellmann, Mark Ashby, Scott Stryker, Richard A. Nash

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

    Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised,... by Sarah A. Holstein, Sin‐Ho Jung, Paul G. Richardson, Craig C. Hofmeister, David D. Hurd, Hani Hassoun, Sergio Giralt, Edward A. Stadtmauer, Daniel J. Weisdorf, Ravi Vij, Jan S. Moreb, Natalie S. Callander, Koen van Besien, Teresa Gentile, Luis Isola, Richard T. Maziarz, Asad Bashey, Heather Landau, Thomas G. Martin, Muzaffar H. Qazilbash, Cesar Rodriguez, Brian McClune, Robert Schlossman, Scott E. Smith, Vera Hárs, Kouros Owzar, Chen Jiang, Molly Boyd, Chelsea Schultz, Marcia Wilson, Parameswaran Hari, Marcelo C. Pasquini, Mary M. Horowitz, Thomas C. Shea, Steven M. Devine, Charles Linker, Kenneth C. Anderson, Philip L. McCarthy

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

    Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma by Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister, David D. Hurd, Hani Hassoun, Paul G. Richardson, Sergio Giralt, Edward A. Stadtmauer, Daniel J. Weisdorf, Ravi Vij, Jan S. Moreb, Natalie S. Callander, Koen van Besien, Teresa Gentile, Luis Isola, Richard T. Maziarz, Don A. Gabriel, Asad Bashey, Heather Landau, Thomas G. Martin, Muzaffar H. Qazilbash, Denise Levitan, Brian McClune, Robert Schlossman, Vera Hárs, John Postiglione, Chen Jiang, Elizabeth Bennett, Susan Barry, Linda R. Bressler, Michael E. Kelly, Michele Seiler, Cara A. Rosenbaum, Parameswaran Hari, Marcelo C. Pasquini, Mary M. Horowitz, Thomas C. Shea, Steven M. Devine, Kenneth C. Anderson, Charles Linker

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: